Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
Join our Virtual Triathlon Challenge and swim, cycle and run while raising money to fund Breakthrough T1D’s life-changing type 1 research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > Knowledge & support > Resource hub > Could the new Health and Care Bill provide greater access to type 1 diabetes technology?
This week the government presented its new Health and Care Bill to MPs. This is the first major shake up to NHS England in nearly a decade, and will build on lessons learned from the coronavirus pandemic. Supporting the NHS to innovate and addressing the health inequalities exposed by the pandemic are key pillars of the reforms in the bill.
Health is devolved in the UK, so yesterday’s bill will affect people in England only. But it will impact how Breakthrough T1D UK speaks out for people with type 1 diabetes right across the UK.
The government is looking to continue the momentum of clinical research and support innovative new developments, potentially paving the way for new treatments and technologies for type 1 diabetes.
The coronavirus pandemic also laid bare the stark inequalities people face around their health, with disparate access to today’s existing technology to help people manage their type 1 diabetes. The bill contains reforms of the current Clinical Commissioning Groups (CCGs) that decide which health services are provided in their local areas, replacing them with Integrated Care Systems (ICSs). The aim is to deliver more integrated care and support, and ensure best practice across England. This could help begin to eradicate the postcode lottery people with type 1 diabetes face in accessing technology.
Other measures announced in the bill are about embracing innovation, promoting patient choice, and maximising the benefit of using data to drive research into new treatments.
Breakthrough T1D UK is hopeful that the bill will offer a key opportunity to deliver innovative new treatments and technologies for type 1 diabetes, as well as widened access to what already exists. The bill must empower people with type 1 to take charge of their own healthcare. Breakthrough T1D UK will promote the voices of everyone in the UK affected by type 1 diabetes, especially those from under-served communities, as we propose changes to the bill as it progresses through Parliament.
Breakthrough T1D UK’s Pathway To Choice partnership project aims to increase awareness of and access to type 1 diabetes technology. The project’s 2020 report, launched in Parliament, highlights barriers to greater type 1 diabetes technology access and makes proposals for these barriers to be overcome.
Read about Pathway to Choice here.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.